Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: GNC ginseng recall

This article was originally published in The Tan Sheet

Executive Summary

GNC ginseng recall: General Nutrition Companies conducts national recall of its Ginseng Gold Panax Ginseng Extract. Initiated earlier in July, the recall was prompted by New York state concerns that liquid ginseng extracts contain a "high percentage" of undeclared alcohol. Announcing July 10 a general recall of over 75 liquid ginseng products, the New York Department of Agriculture and Markets warns the products are "mislabeled" and will be seized if not voluntarily removed. The department maintains the products contain up to 24% alcohol and are packaged "in such a way as to appeal to children as an alcoholic beverage." The products typically are available in glass vials containing 9.5-10 mL of liquid. A New York state lab analysis found that Ginseng Gold contained 15.7% alcohol. GNC said it will sponsor a third-party analysis of its product and thereafter will consider relabeling or reformulation. Other manufacturers/distributors include Action Labs, Delta Distributors, Precise Nutrition International and Prince of Peace Enterprises International...

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

People In Brief

Perrigo promotes in pricing, planning

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS087317

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel